Loading...
Loading...
Jefferies is out with its report today on Cepheid
CPHD, raising its PT from $30 to $35.
In a note to clients, Jefferies writes, "CPHD's 1Q11 GAAP EPS of $0.01 was $0.02 ahead of consensus on better than expected revenue growth and profit trends. We are raising our 2011 and 2012 EPS forecasts to $0.03 (from $0.02) and $0.52 (from $0.50), respectively. Our PT moves to $35 (from $30) on higher cash flow forecasts."
Jefferies maintains Buy on CPHD.
Shares of CPHD closed Wednesday at $30.71.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in